Pharmaceutical Packaging and Unit of Issue Compliance
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract entails the repackaging and labeling of Adenosine Injection to comply with the Defense Logistics Agency’s ANSI X12 unit of issue standards, NSN marking requirements, and federal supply system protocols. All work must be performed in a sterile environment to maintain product integrity and regulatory compliance, ensuring the medication meets stringent military and federal pharmaceutical standards. The activity is classified under NAICS code 325999 and is structured as a subcontract under the Department of Defense, with performance tied to the DLA’s logistical and supply chain mandates. The contract was posted in August 2026 and is associated with the award SPE2DX25D8022, with delivery order SPE2D926F8091, indicating its integration into the broader defense supply network.
General Info
NAICS
Place of Performance
Not specifiedSet-Aside
Documents
This scope was carved out of SPE2D926F8091.
The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.
ADENOSINE INJECTION
AI Contract Breakdown
Uniform Contract FormatNo documents to break down
The breakdown needs solicitation documents. None were found from this contract's source.
Timeline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Defense → Defense Logistics Agency
Same awarding agency
Ready to Pursue This Opportunity?
Get AI-powered intelligence on this solicitation and the ones like it
Every page of the solicitation package shredded into a compliance breakdown
AI-powered matching based on your capabilities and past performance
Competitor and incumbent history on the requirement
Automated alerts on amendments, Q&A deadlines, and award
Join 750+ contractors already using CLEATUS
